Drug2ways: Reasoning over causal paths in biological networks for drug discovery.
Elucidating the causal mechanisms responsible for disease can reveal potential therapeutic targets for pharmacological intervention and, accordingly, guide drug repositioning and discovery. In essence, the topology of a network can reveal the impact a drug candidate may have on a given biological st...
Main Authors: | Daniel Rivas-Barragan, Sarah Mubeen, Francesc Guim Bernat, Martin Hofmann-Apitius, Daniel Domingo-Fernández |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-12-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1008464 |
Similar Items
-
PathMe: merging and exploring mechanistic pathway knowledge
by: Daniel Domingo-Fernández, et al.
Published: (2019-05-01) -
DecoPath: a web application for decoding pathway enrichment analysis
by: Bharadhwaj, V.S, et al.
Published: (2021) -
Using predictive machine learning models for drug response simulation by calibrating patient-specific pathway signatures
by: Bharadhwaj, V.S, et al.
Published: (2021) -
From bench to bedside: ways and steps of drug discovery
by: Ş.Ş. Alkan
Published: (2011-12-01) -
PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures
by: Mohammad Asif Emon, et al.
Published: (2020-06-01)